Tate & Lyle Ventures logo

Tate & Lyle Ventures

Europe, England, United Kingdom, London

Description

Tate & Lyle Ventures is a venture capital fund invests in high growth companies in the fields of food science and technology .

Investor Profile

Tate & Lyle Ventures has made 15 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series Unknown (40%)
  • Series C (20%)
  • Series B (20%)
  • Series A (13%)
  • Seed (7%)

Country Focus

  • United States (47%)
  • United Kingdom (40%)
  • Germany (7%)
  • Belgium (7%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Agriculture
  • Biofuel
  • Food And Beverage
  • Health Diagnostics
  • Nutrition
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tate & Lyle Ventures frequently co-invest with?

Pasadena Angels
North America, California, United States, Altadena
Co-Investments: 2
Highlands and Islands Enterprise
Europe, Stockholms Lan, Sweden, Inverness
Co-Investments: 2
Aescap Venture
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 2
Horizons Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 2
NV
Europe, England, United Kingdom, London
Co-Investments: 2
Bluegrass Angels
North America, Kentucky, United States, Lexington
Co-Investments: 2
Ag Fund
Asia, Ar Riyad, Saudi Arabia, Riyadh
Co-Investments: 1
Catapult Ventures
Europe, Leicester, United Kingdom, Enderby
Co-Investments: 2
Tech Coast Angels
North America, California, United States, Newport Beach
Co-Investments: 2

What are some of recent deals done by Tate & Lyle Ventures?

Changing Health

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

Changing Health provides personalised, digital behaviour change programmes for Type 2 diabetes, pre-diabetes, and weight management.

AppsDiabetesEducationHealth Care
SeedDec 18, 2018
Amount Raised: $3,796,454
Prolupin

Grimmen, Mecklenburg-Vorpommern, Germany

Prolupin develops, produces, and markets vegetable-based, lactose-free milk substitutes from the blue sweet lupine.

BiotechnologyFood and BeverageFood ProcessingManufacturing
Series UnknownMay 8, 2018
Evolve Biosystems

Davis, California, United States

Evolve Biosystems provides microbiome-based products.

BiotechnologyHealth CareMedicalMedical Device
Series BMay 30, 2017
Amount Raised: $20,000,000
Nutriati

Richmond, Virginia, United States

Nutriati is a plant-based food and beverage ingredient company creating functional powders and flours for consumer brands.

Alternative ProteinBiotechnologyFood and BeverageNutritionPlant-Based Foods
Series AApr 21, 2017
Amount Raised: $8,000,000
Evolve Biosystems

Davis, California, United States

Evolve Biosystems provides microbiome-based products.

BiotechnologyHealth CareMedicalMedical Device
Series AAug 17, 2015
Amount Raised: $9,000,000
Lumora

Ely, Cambridgeshire, United Kingdom

Lumora develops work flow-based solutions that simplify clinical diagnostics, industrial microbiology, and sample preparation.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownMar 19, 2013
Amount Raised: $1,056,751
Allylix

San Diego, California, United States

Allylix develops terpene products for flavor and fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.

AgricultureBiofuelBiotechnologyPharmaceutical
Series UnknownMar 12, 2012
Amount Raised: $18,200,000
Lumora

Ely, Cambridgeshire, United Kingdom

Lumora develops work flow-based solutions that simplify clinical diagnostics, industrial microbiology, and sample preparation.

BiotechnologyHealth CareHealth Diagnostics
Series BMay 26, 2011
Amount Raised: $2,452,527
Allylix

San Diego, California, United States

Allylix develops terpene products for flavor and fragrance, food ingredients, pharmaceuticals, agricultural and biofuels markets.

AgricultureBiofuelBiotechnologyPharmaceutical
Series CApr 13, 2010
Amount Raised: $3,000,000
Aquapharm Biodiscovery

Newyork, Argyll and Bute, United Kingdom

Aquapharm Biodiscovery is a drug discovery company developing products based on the chemical diversity of marine microorganisms.

BiotechnologyChemicalPharmaceutical
Series CApr 5, 2010
Amount Raised: $6,400,000